Company: GVH
Filing Date: 2025-07-01
Form Type: 6-K
Source: 0001213900-25-060374
Chunk: 1

Company: Globavend Holdings Ltd
Filing Date: 2025-07-01
Form: 6-K
Chunk 1
---
eth (30) calendar day (the “Reset Date”)
following the issuance date of the Series A Warrants to a price equal to 105% of the arithmetic average of the sum of the three lowest
per share VWAPs (as defined in the Series A Warrant) of the Ordinary Shares on Nasdaq for the twenty (20) trading days immediately
prior to the Reset Date, provided that such price shall not be lower than $0.1395 (the “Floor Price”).

Each Series B Warrant
will have an exercise price per share equal to 170% of the price per Ordinary Unit sold in this Offering, or $1.173. A holder of Series B
Warrants may, at any time and in its sole discretion, exercise its Series B Warrants in whole or in part by means of a “zero
price exercise” option in which the holder is entitled to receive a number of Ordinary Shares equal to the product of (a) the
number of Ordinary Shares that would be issuable upon exercise of the Series B Warrant in accordance with the terms of such Series B
Warrant if such exercise were by means of a cash exercise rather than a cashless exercise and (b) the quotient obtained by dividing
(i) the exercise price minus the lowest VWAP (as defined in the Series B Warrant) of the Ordinary Shares during the five (5) trading
days immediately prior to the applicable exercise date (such VWAP, the “Low Price”) by (ii) 50% of the Low Price. This
“zero price exercise” option is only available at a time when the applicable Low Price is lower than the then applicable exercise
price. At no time can the Low Price be lower than the Floor Price. Accordingly, if the holder elects the zero price exercise option, the
number of shares of Ordinary Shares issuable upon exercise of the Series B Warrants could increase to up to an aggregate of 322,113,130,
assuming the Low Price equals the Floor Price at the time of such election.

<div align='center'>1</div>

The securities in the Offering
are being offered pursuant to a securities purchase agreement with certain investors (the “Securities Purchase Agreement”)
and the Company’s registration statement on Form F-1 (File No. 333-287533), as amended, which was initially filed with the Securities
and Exchange Commission (the “SEC”) on May 23, 2025 and was declared effective by the